PMS’s new report outlines solutions to protect patient safety in the growing compounded GLP-1 marketplace. A Call to Action: Restoring and Strengthening America’s Patient Safety System serves as a roadmap for policymakers and regulators to uphold the gold standard system that protects Americans from untested and unsafe medicines.
AFPs, which often force patients to source medicines overseas, may present access concerns according to a new study.
Similar importation programs have been plagued with logistical hurdles, despite extensive funding of the efforts.
“Colorado is now poised to repeat Florida’s failed attempt to implement Canadian drug importation,” said PSM Executive Director Shabbir Imber Safdar. “Since beginning their program in 2019, Florida has spent $132 million and still not imported a single unit of medicine, proving that these bulk importation programs are not reducing drug costs for Americans.”
As the popularity of peptides skyrockets, consumers should be asking questions about where their drugs come from. Here’s what we found in shipment data for peptides in Q1.
Retatrutide, an experimental weight loss drug that hasn’t been submitted for FDA-approval, is being prescribed in weight loss clinics and med spas across the country.
March and April 2026 saw thousands of shipments of drugs imported into the US, including weight loss drugs and antibiotics. We studied these shipments to learn more about their manufacturers and contents.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
How're smugglers getting peptides into the country?
14 were arrested in connection with a nationwide counterfeit drug operation.
A recent FDA warning letter highlights upstream supply chain vulnerabilities.
Click the images below to see more recent videos.